Compounds > moxonidine

Page last updated: 2024-08-16

moxonidine and pefloxacin

moxonidine has been researched along with pefloxacin in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	5 (71.43)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Campillo, NE; Guerra, A; Páez, JA	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Hennig, S; Karlsson, MO	1
Karlsson, MO; Svensson, EM	1
Bergstrand, M; Dosne, AG; Harling, K; Karlsson, MO	1

Other Studies

7 other study(ies) available for moxonidine and pefloxacin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Concordance between criteria for covariate model building. Journal of pharmacokinetics and pharmacodynamics, 2014, Volume: 41, Issue:2 Topics: Docetaxel; Humans; Imidazoles; Leukocyte Count; Models, Biological; Neutrophils; Pefloxacin; Pharmacokinetics; Prazosin; Stochastic Processes; Taxoids	2014
Use of a linearization approximation facilitating stochastic model building. Journal of pharmacokinetics and pharmacodynamics, 2014, Volume: 41, Issue:2 Topics: Ethambutol; Humans; Imidazoles; Models, Biological; Nonlinear Dynamics; Pefloxacin; Pharmacokinetics; Software; Stochastic Processes	2014
Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling. Journal of pharmacokinetics and pharmacodynamics, 2016, Volume: 43, Issue:6 Topics: Administration, Oral; Algorithms; Computer Simulation; Confidence Intervals; Humans; Imidazoles; Injections, Intravenous; Models, Biological; Models, Statistical; Nonlinear Dynamics; Pefloxacin; Phenobarbital; Software; Uncertainty	2016